Company Filing History:
1 out of 1 
1 out of 832,843 Years Active: 2013-2015
Title: Susanne Lindquist: Innovator in Rheumatoid Arthritis Treatment
Introduction
Susanne Lindquist is a prominent inventor based in Roback, Sweden. She has made significant contributions to the field of medical research, particularly in the treatment of inflammatory diseases such as rheumatoid arthritis. With a total of 2 patents, her work focuses on innovative methods that utilize antibodies to combat these conditions.
Latest Patents
Lindquist's latest patents include groundbreaking methods for treating juvenile arthritis and rheumatoid arthritis using anti-bile salt-stimulated lipase (BSSL) antibodies. These patents provide pharmaceutical compositions that comprise antagonists to the protein Bile Salt-Stimulated Lipase (BSSL). The inventions aim to prevent, prophylax, and treat inflammatory diseases, particularly rheumatoid arthritis. The suitable BSSL antagonists identified for use in these methods are BSSL antibodies, which have shown promise in therapeutic applications.
Career Highlights
Throughout her career, Susanne Lindquist has worked with various companies, including Lipum AB. Her research has been pivotal in advancing the understanding and treatment of rheumatoid arthritis, showcasing her dedication to improving patient outcomes through innovative solutions.
Collaborations
Lindquist has collaborated with notable colleagues such as Olle Hernell and Lennart Gustav Lundberg. These partnerships have contributed to her success and the development of her patented methods.
Conclusion
Susanne Lindquist's contributions to the field of rheumatoid arthritis treatment through her innovative patents highlight her role as a leading inventor in medical research. Her work continues to pave the way for new therapeutic approaches that can significantly impact patient care.